Compounding Effects of APOE4 and Blood Neurodegenerative Biomarkers on Cognitive Decline in Community‐dwelling Older Adults

Abstract

Background: Scarce population‐based data exist on whether APOE4 carrier status accelerates the rate of cognitive decline in non‐demented older adults with elevated neurodegenerative burden.